At CRGH we are pleased to be able to offer you the most accurate form of Down syndrome screening, in the form of the Non-Invasive Prenatal Test (NIPT). A non-invasive prenatal test (NIPT) analyses the DNA circulating in the pregnant mother’s blood from 10 week’s gestation. Our NIPT test is provided by Juno Genetics in the form of a “NEO test”.
NeoTest is a non-invasive prenatal test, performed with maternal blood, totally safe for the mother and foetus. It is performed at 10 week’s gestation and is used to detect hypothetical chromosomal abnormalities that can lead to late miscarriage or the birth of a child with severe congenital anomalies.
Juno’s Neo5® test is currently the most advanced non-invasive pregnancy screening test available for parents who need to know their baby’s risk of Down syndrome, Edwards’ syndrome or Patau’s syndrome. It also reveals the possible existence of abnormalities in the X and Y sex chromosomes
An NIPT test can be requested for any singleton or twin pregnancies, including in vitro fertilisation (IVF) pregnancies with egg donors. The NIPT Test is now the most accurate non invasive screening for the most common aneuploidies.
Abnormalities in individual genes are not detectable. If you have a personal or family history of a specific genetic condition, please book a consultation with our Genetic Counsellor before proceeding with any tests.
Results take 10 working days.
For more information please contact us on +44 (0)20 7837 2905 or firstname.lastname@example.org uk.